Fujirebio Diagnostics Inc - Company & Market Research Reports

Home /
Companies /
Fujirebio Diagnostics Inc

Fujirebio Diagnostics manufactures and supplies in vitro diagnostics and biomarkers. Fujirebio Diagnostics specializes in the manufacturing of manual assay products, reagents and controls distributed throughout the U.S. and around the world, as well as custom-developed products for use through our worldwide network of distribution partners. The company was founded in 1979 and is based in Malvern, Pennsylvania with manufacturing facilities in Malvern, Pennsylvania; Seguin, Texas; and Goteborg, Sweden.

REFINE BY

KEYWORD

2021-2025 Asia-Pacific Tumor Markers Business Opportunities in 17 Countries - Oncogenes, Bio Markers, GFs, CSFs, Hormones, Stains, Lymphokines

 Report
November 2021
Asia Pacific

From

€12806EUR$14,500USD£10,938GBP

2021-2025 Spain Tumor Markers Business Opportunities - Oncogenes, Bio Markers, GFs, CSFs, Hormones, Stains, Lymphokines

 Report
November 2021
Spain

From

€3091EUR$3,500USD£2,640GBP

2021-2025 Europe Tumor Markers Business Opportunities in 38 Countries - Oncogenes, Bio Markers, GFs, CSFs, Hormones, Stains, Lymphokines

 Report
November 2021
Europe

From

€21638EUR$24,500USD£18,481GBP

2021-2025 U.K. Tumor Markers Business Opportunities - Oncogenes, Bio Markers, GFs, CSFs, Hormones, Stains, Lymphokines

 Report
November 2021
United Kingdom

From

€3091EUR$3,500USD£2,640GBP

2021-2025 Latin America Tumor Markers Business Opportunities in 22 Countries - Oncogenes, Bio Markers, GFs, CSFs, Hormones, Stains, Lymphokines

 Report
November 2021
Latin America

From

€12806EUR$14,500USD£10,938GBP

NEED HELP FINDING THE RIGHT PRODUCT? Brian will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

2021-2025 U.S. Tumor Markers Business Opportunities - Oncogenes, Bio Markers, GFs, CSFs, Hormones, Stains, Lymphokines

 Report
November 2021
United States

From

€3091EUR$3,500USD£2,640GBP

2021-2025 Germany Tumor Markers Business Opportunities - Oncogenes, Bio Markers, GFs, CSFs, Hormones, Stains, Lymphokines

 Report
November 2021
Germany

From

€3091EUR$3,500USD£2,640GBP

2021-2025 Europe Tumor Markers Business Opportunities - France, Germany, Italy, Spain, UK - Oncogenes, Bio Markers, GFs, CSFs, Hormones, Stains, Lymphokines

 Report
November 2021
France, Germany, ... France, Germany, Italy, Spain, United Kingdom, Europe

From

€12806EUR$14,500USD£10,938GBP

2021-2025 Global Tumor Markers Business Opportunities - USA, Europe, Japan - Oncogenes, Bio Markers, GFs, CSFs, Hormones, Stains, Lymphokines

 Report
November 2021
Global, Europe, United States, ... Global, Europe, United States, Japan

From

€21638EUR$24,500USD£18,481GBP

2021-2025 North America Tumor Markers Business Opportunities - USA, Canada, Mexico - Oncogenes, Bio Markers, GFs, CSFs, Hormones, Stains, Lymphokines

 Report
November 2021
Canada, Mexico, North America Canada, Mexico, North America

From

€8390EUR$9,500USD£7,166GBP

2021-2025 France Tumor Markers Business Opportunities - Oncogenes, Bio Markers, GFs, CSFs, Hormones, Stains, Lymphokines

 Report
November 2021
France

From

€3091EUR$3,500USD£2,640GBP

2021-2025 Middle East Tumor Markers Business Opportunities in 11 Countries - Oncogenes, Bio Markers, GFs, CSFs, Hormones, Stains, Lymphokines

 Report
November 2021
Middle East

From

€8390EUR$9,500USD£7,166GBP

2021 South Africa Tumor Marker Market Assessment - Competitive Shares and Strategies, Volume and Sales Segment Forecasts, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers

 Report
March 2021
535 Pages
South Africa

From

€3091EUR$3,500USD£2,640GBP

2021 India Tumor Marker Market Assessment - Competitive Shares and Strategies, Volume and Sales Segment Forecasts, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers

 Report
March 2021
535 Pages
India

From

€3091EUR$3,500USD£2,640GBP

Genetic Testing Markets. Global Market Analysis with Forecasts by Applications, Technologies, Products and Users with Executive and Consultant Guides 2023 to 2027

 Report
June 2025
565 Pages
Global

From

€6178EUR$6,995USD£5,276GBP

2024 Indonesia Tumor Marker Sales Segment Forecasts: Supplier Shares and Strategies, Emerging Tests, Technologies and Opportunities

 Report
June 2020
535 Pages
Indonesia

From

€3091EUR$3,500USD£2,640GBP

2024 Thailand Tumor Marker Sales Segment Forecasts: Supplier Shares and Strategies, Emerging Tests, Technologies and Opportunities

 Report
June 2020
535 Pages
Thailand

From

€3091EUR$3,500USD£2,640GBP

COVID-19 Rapid Test Kits Market Report 2025

 Report
March 2025
250 Pages
Global

From

€3965EUR$4,490USD£3,387GBP

Distribution Deals in Diagnostics 2016 to 2025

 Report
April 2025
250 Pages
Global

From

€3528EUR$3,995USD£3,014GBP

Human Gene Sequencing Markets, Strategies & Trends: Forecasts By Application, By Technology, By Workflow, By Product, and By Country with Executive and Consultant Guides

 Report
June 2025
835 Pages
Global

From

€6178EUR$6,995USD£5,276GBP

1,557 Results (Page 30 of 78)
- 1
- 28
- 29
- 30
- 31
- 32

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.